(2-Benzhydryloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetic acid, 97.0%, 5g

Quinazoline-2,4-diamine, 95.0%, 1g

2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide, 95.0%, 5mg

(5E)-2-mercapto-5-(3-methoxybenzylidene)-1,3-thiazol-4(5H)-one, 95.0%, 5g

5-Aminobenzimidazole, 97.0%, 5g

Sample tub Type 2116, 60 ml, 4 Piece(s)

4-Amino-2-chloro-5-methylpyrimidine, 95.0%, 10g

ETHYL 5-BROMOBENZOFURAN-2-CARBOXYLATE, 97.0%, 100g

fmoc-b-homo-d-tyr(tbu)-oh, 98.0%, 1g

methyl (1s,2R,3r,8S)-4-acetylcubane-1-carboxylate, 95.0%, 100mg

2-((DIPHENYLBORYL)OXY)ETHANAMINE, 95%, 5g

Trimethylsilyl Methacrylate (stabilized with BHT)>98.0%(GC)5mL

methyl 5-(3-methoxyphenyl)isoxazole-3-carboxylate, 95.0%, 10g